1-6 of 6
Masato Nakamura
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study

Available to Purchase
Kazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta, Tomomi Okubo, Norio Itokawa, Yuki Haga, Yuya Seko, Michihisa Moriguchi, Shunji Watanabe, Yuki Shiko, Hirokazu Takatsuka, Hiroaki Kanzaki, Keisuke Koroki, Masanori Inoue, Masato Nakamura, Soichiro Kiyono, Naoya Kanogawa, Takayuki Kondo, Eiichiro Suzuki, Yoshihiko Ooka, Shingo Nakamoto, Yosuke Inaba, Masafumi Ikeda, Shinichiro Okabe, Naoki Morimoto, Yoshito Itoh, Kazuyoshi Nakamura, Kenji Ito, Ryosaku Azemoto, Masanori Atsukawa, Ei Itobayashi, Naoya Kato
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (23): 4760–4769.
https://doi.org/10.1158/1078-0432.CCR-23-1462
Published: 01 December 2023
View articletitled, A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study
Open the PDF for A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study in another window
Includes: Supplementary data
Journal Articles

Abstract B38: Clinical applications of PDX/NOG models for personalized chemotherapy – possible use in chemo-sensitivity testing and clinical sequencing

Free
Tsuyoshi Chijiwa, Takayuki Isagawa, Akira Noguchi, Hidemitsu Sato, Akimune Hayashi, Haruhiko Cho, Manabu Shiozawa, Takeshi Kishida, Soichiro Morinaga, Tomoyuki Yokose, Makoto Katayama, Nobuo Takenaka, Mizuha Haraguchi, Naoki Miyao, Yuichi Tateishi, Kenji Kawai, Hiroshi Suemizu, Roppei Yamada, Yoshiyasu Nakamura, Kohzoh Imai, Daisuke Komura, Shumpei Ishikawa, Masato Nakamura, Yohei Miyagi
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16_Supplement): B38.
https://doi.org/10.1158/1557-3265.PDX16-B38
Published: 15 August 2016
View articletitled, Abstract B38: Clinical applications of PDX/NOG models for personalized chemotherapy – possible use in chemo-sensitivity testing and clinical sequencing
Journal Articles

Combination of IFN- α and 5-Fluorouracil Induces Apoptosis through IFN-α/β Receptor in Human Hepatocellular Carcinoma Cells

Available to Purchase
Motoi Kondo, Hiroaki Nagano, Hiroshi Wada, Bazarragchaa Damdinsuren, Hirofumi Yamamoto, Nobuaki Hiraoka, Hidetoshi Eguchi, Atsushi Miyamoto, Tameyoshi Yamamoto, Hideo Ota, Masato Nakamura, Shigeru Marubashi, Keizo Dono, Koji Umeshita, Shoji Nakamori, Masato Sakon, Morito Monden
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (3): 1277–1286.
https://doi.org/10.1158/1078-0432.1277.11.3
Published: 11 February 2005
View articletitled, Combination of IFN- α and 5-Fluorouracil Induces Apoptosis through IFN-α/β Receptor in Human Hepatocellular Carcinoma Cells
Open the PDF for Combination of IFN- α and 5-Fluorouracil Induces Apoptosis through IFN-α/β Receptor in Human Hepatocellular Carcinoma Cells in another window
Journal Articles

Partial Contribution of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)/TRAIL Receptor Pathway to Antitumor Effects of Interferon-α/5-Fluorouracil against Hepatocellular Carcinoma

Available to Purchase
Tameyoshi Yamamoto, Hiroaki Nagano, Masato Sakon, Hisashi Wada, Hidetoshi Eguchi, Motoi Kondo, Bazarragchaa Damdinsuren, Hideo Ota, Masato Nakamura, Hiroshi Wada, Shigeru Marubashi, Atsushi Miyamoto, Keizo Dono, Koji Umeshita, Shoji Nakamori, Hideo Yagita, Morito Monden
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (23): 7884–7895.
https://doi.org/10.1158/1078-0432.CCR-04-0794
Published: 07 December 2004
View articletitled, Partial Contribution of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)/TRAIL Receptor Pathway to Antitumor Effects of Interferon-α/5-Fluorouracil against Hepatocellular Carcinoma
Open the PDF for Partial Contribution of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)/TRAIL Receptor Pathway to Antitumor Effects of Interferon-α/5-Fluorouracil against Hepatocellular Carcinoma in another window
Journal Articles

Use of 11p15 Mucins as Prognostic Factors in Small Adenocarcinoma of the Lung

Available to Purchase
Noboru Nishiumi, Yoshiyuki Abe, Yoshimasa Inoue, Hiroyuki Hatanaka, Ken-ichi Inada, Hiroshi Kijima, Hitoshi Yamazaki, Masae Tatematsu, Yoshito Ueyama, Masayuki Iwasaki, Hiroshi Inoue, Masato Nakamura
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (15): 5616–5619.
Published: 03 December 2003
View articletitled, Use of 11p15 Mucins as Prognostic Factors in Small Adenocarcinoma of the Lung
Open the PDF for Use of 11p15 Mucins as Prognostic Factors in Small Adenocarcinoma of the Lung in another window
Journal Articles

Significant Correlation between Interleukin 10 Expression and Vascularization through Angiopoietin/TIE2 Networks in Non-small Cell Lung Cancer

Available to Purchase
Hiroyuki Hatanaka, Yoshiyuki Abe, Masao Naruke, Tetsuji Tokunaga, Yoshiro Oshika, Tsutomu Kawakami, Hideo Osada, Junko Nagata, Jun-ichiro Kamochi, Takashi Tsuchida, Hiroshi Kijima, Hitoshi Yamazaki, Hiroshi Inoue, Yoshito Ueyama, Masato Nakamura
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (5): 1287–1292.
Published: 01 May 2001
View articletitled, Significant Correlation between Interleukin 10 Expression and Vascularization through Angiopoietin/TIE2 Networks in Non-small Cell Lung Cancer
Open the PDF for Significant Correlation between Interleukin 10 Expression and Vascularization through Angiopoietin/TIE2 Networks in Non-small Cell Lung Cancer in another window